The Magnet® effect: Success in minimizing bloodstream infections
One hospital’s Magnet quest and several other factors came together to reduce the infection rate.
Immune/Lymphatic System
Chemotherapy and Biotherapy Drugs for Autoimmune Disease
New biotherapy drugs and older chemotherapy agents may improve quality of life in patients with autoimmune diseases.
Updated guidelines for managing occupational HIV exposure released
Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations…
Is your wound-cleansing practice up to date?
Do you know how to choose-and correctlyuse-the appropriate agent to clean your patient’s wound?
Be prepared for poison ivy, oak, and sumac
The author clears up misconceptions and discusses treatment.
FDA approves first anti-diarrheal drug for HIV/AIDS patients
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral…
Helping patients survive sepsis
In its early stages, sepsis can be difficult to detect. Learn about the sometimes-subtle signs and symptoms.
FDA approves Xeljanz for rheumatoid arthritis
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who…
Essential elements of a comprehensive sharps injury-prevention program
The steps outlined below can help facilities significantly reduce sharps injuries.
Preventing catheter-related bloodstream infections related to I.V. connectors
The author provides an overview of the issue and suggests some solutions.
The Magnet® effect: Success in minimizing bloodstream infections
One hospital’s Magnet quest and several other factors came together to reduce the infection rate.
Chemotherapy and Biotherapy Drugs for Autoimmune Disease
New biotherapy drugs and older chemotherapy agents may improve quality of life in patients with autoimmune diseases.
Updated guidelines for managing occupational HIV exposure released
Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus…
Is your wound-cleansing practice up to date?
Do you know how to choose-and correctlyuse-the appropriate agent to clean your patient’s wound?
Be prepared for poison ivy, oak, and sumac
The author clears up misconceptions and discusses treatment.
FDA approves first anti-diarrheal drug for HIV/AIDS patients
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients…
Helping patients survive sepsis
In its early stages, sepsis can be difficult to detect. Learn about the sometimes-subtle signs and symptoms.
FDA approves Xeljanz for rheumatoid arthritis
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid…
Essential elements of a comprehensive sharps injury-prevention program
The steps outlined below can help facilities significantly reduce sharps injuries.
Preventing catheter-related bloodstream infections related to I.V. connectors
The author provides an overview of the issue and suggests some solutions.
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.